Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Fine

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
Cancer Research|June 3, 2004
Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivoWei Chen, Jeongwu Lee, Steve Y Cho, et al.
Glia|May 7, 2011
Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchyMonica Venere, Howard A Fine, Peter B Dirks, et al.
Journal of Neuro-Oncology|August 8, 2014
Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohortYazmin Odia, Joanna H Shih, Teri N Kreisl, et al.
Neurosurgical Focus|October 1, 2020
Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patientsChibawanye I Ene, Patrick J Cimino, Howard A Fine, et al.
Cell Stem Cell|May 12, 2009
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastomaMyung Jin Son, Kevin Woolard, Do-Hyun Nam, et al.
Journal of Neuro-Oncology|August 20, 2015
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomasYazmín Odia, Teri N Kreisl, Dawit Aregawi, et al.
Biophysical Journal|November 10, 2011
Qualitative network modeling of the Myc-p53 control system of cell proliferation and differentiationBaltazar D Aguda, Yangjin Kim, Hong Sug Kim, et al.
Archives of Dermatology|August 19, 2009
Cutaneous pigmentation after photosensitivity induced by vandetanib therapyHeidi H Kong, Howard A Fine, Jere B Stern, et al.
BMC Medical Genomics|April 13, 2010
CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterationsYuri Kotliarov, Serdar Bozdag, Hangjiong Cheng, et al.
Molecular Cancer Research : MCR|February 12, 2009
Rembrandt: helping personalized medicine become a reality through integrative translational researchSubha Madhavan, Jean-Claude Zenklusen, Yuri Kotliarov, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
Cancer Research|June 3, 2004
Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivoWei Chen, Jeongwu Lee, Steve Y Cho, et al.
Glia|May 7, 2011
Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchyMonica Venere, Howard A Fine, Peter B Dirks, et al.
Journal of Neuro-Oncology|August 8, 2014
Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohortYazmin Odia, Joanna H Shih, Teri N Kreisl, et al.
Neurosurgical Focus|October 1, 2020
Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patientsChibawanye I Ene, Patrick J Cimino, Howard A Fine, et al.
Cell Stem Cell|May 12, 2009
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastomaMyung Jin Son, Kevin Woolard, Do-Hyun Nam, et al.
Journal of Neuro-Oncology|August 20, 2015
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomasYazmín Odia, Teri N Kreisl, Dawit Aregawi, et al.
Biophysical Journal|November 10, 2011
Qualitative network modeling of the Myc-p53 control system of cell proliferation and differentiationBaltazar D Aguda, Yangjin Kim, Hong Sug Kim, et al.
Archives of Dermatology|August 19, 2009
Cutaneous pigmentation after photosensitivity induced by vandetanib therapyHeidi H Kong, Howard A Fine, Jere B Stern, et al.
BMC Medical Genomics|April 13, 2010
CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterationsYuri Kotliarov, Serdar Bozdag, Hangjiong Cheng, et al.
Molecular Cancer Research : MCR|February 12, 2009
Rembrandt: helping personalized medicine become a reality through integrative translational researchSubha Madhavan, Jean-Claude Zenklusen, Yuri Kotliarov, et al.
Pageof 17